COVID-19 / Coronavirus

Happiness Biotech Announces $2.25 Million Private Placement In Support of Happy Buy

2020-09-25 22:30 25012

NANPING, China, Sept. 25, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company has entered into certain securities purchase agreement with three non-U.S. inve...

Solvay introduces Actizone™, a long-lasting antimicrobial cleaning technology

2020-09-24 21:46 2507

Durable surface protection is now within easy reach with Actizone™, a patented technology that delivers 24-hour antimicrobial performance. BRUSSELS, Sept. 24, 2020 /PRNewswire/ -- Solvay is proud to introduce Actizone™

New Centre for Medicines Research Report from Clarivate Indicates Drug Development Timelines are Shortest Since 2013

2020-09-24 16:15 7772

Pharmaceutical R&D industry report provides insights into what's behind decline in global NME outputs and reveals implications of decreased projected expenditures LONDON, Sept. 24, 2020 /PRNewswire/ -- Clarivate Plc (NYSE:CCC), a global leader in providing trusted information and insights to acc...

New Development Bank prices USD 2 billion benchmark bond to further support COVID emergency response

2020-09-24 12:55 1754

* The New Development Bank's (NDB) latest issue in the international capital markets represents another strong step forward in developing its yield curve. * The USD-denominated 5-year COVID Response Bond is yet another demonstration of NDB's commitment to fighting the coronavirus outbreak in i...

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate

2020-09-23 19:25 3306

NEW BRUNSWICK, New Jersey, Sept. 23, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical ...

Vela Diagnostics' SARS-CoV-2 RT-PCR Test v2.0 Authorized for Emergency Use in the U.S.

2020-09-23 12:53 1382

FAIRFIELD, N.J., Sept. 23, 2020 /PRNewswire/ -- Vela Diagnostics announced today that the ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 has obtained the Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). This automated probe-based reverse transcription PCR test detects SAR...

UC Berkeley and Bitmark launch Autonomy app as part of the school's COVID-19 Safe Campus Initiative

2020-09-22 22:00 1084

BERKELEY, Calif., Sept. 22, 2020 /PRNewswire/ -- As part of UC Berkeley's Safe Campus Initiative, the university and BitmarkInc. have partnered to launch Autonomy, a public health app that helps users understand how their local community is managing with COVID-19. In the process, Autonomy enables...

TCM Lianhua Qingwen Capsule approved for registration in Mauritius

2020-09-22 15:21 828

SHIJIAZHUANG, China, Sept. 22, 2020 /PRNewswire/ -- Yiling Pharmaceutical Co., Ltd. (SHE: 002603) announced on Tuesday that it has received a registration approval issued by the Ministry of Health and Wellness ofMauritius, indicating Lianhua Qingwen Capsule has been registered in accordance with ...

Gates Foundation Honors Director of Africa CDC With 2020 Global Goalkeeper Award

2020-09-22 12:01 1683

Foundation also announces three Global Goals award winners and launches two innovative partnerships to address COVID-19 impacts inKenya SEATTLE, Sept. 22, 2020 /PRNewswire/ -- The Bill & Melinda Gates Foundation today named Dr. John N. Nkengasong, director of the Africa Centres for Disease Contr...

Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supply

2020-09-22 07:00 11491

INCHEON, South Korea, Sept. 21, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and AstraZeneca announced a long-term supply agreement, valued at approximately $330.8 million. Under this agreement, Samsung Biologics will provide large-scale commercial manufacturing for drug substance in its Pla...

Amazfit Band 5 Launched with Blood Oxygen Saturation, 15-day Battery Life[1] at 49.9USD[2] on Sept. 21st, and Amazon Alexa Built-in[3] Coming Soon

2020-09-22 00:00 2392

Can A Band Be Smarter? Check this All-round Band with Varied Health Management and Alexa Built-in. SHENZHEN, China, Sept. 21, 2020 /PRNewswire/ -- Amazfit Band 5, a smart wrist band, launched as the latest offering of Huami to the excellence of Amazfit wearable lineup. Amazfit Band 5 featur...

Ortho Awarded BARDA Contract to Accelerate Antigen Test Development and Additional SARS-CoV-2 Antibody Test Milestones

2020-09-21 21:00 1666

RARITAN, N.J., Sept. 21, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced its continued collaboration with the Biomedical Advanced Research and Development Authority ( BARDA), part of the Office of the Assistant Secretary for Preparedness an...

China Pharmaceutical Holdings Co., Ltd. Has Obtained Multiple Certifications for Its Masks

2020-09-21 20:30 12455

HAIKOU CITY, China, Sept. 21, 2020 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that the masks produced by ...

Harbour BioMed Announces Two China NMPA Clearances for Clinical Trials for Phase I & Combination Therapy of Next Generation Anti-CTLA-4 Antibody for Treatment of Solid Tumors

2020-09-21 20:12 2004

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 21, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global, clinical-stage, innovative biopharmaceutical company announced approval of two Investigational New Drug (IND) applications by the China National Medical Products Administr...

I-Mab Announces China NMPA Clearance for Phase 1 Clinical Trial of Lemzoparlimab in Relapsed or Refractory Advanced Lymphoma

2020-09-21 20:00 5202

SHANGHAI and GAITHERSBURG, Md., Sept. 21, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Center for Drug Evaluation (CDE) of the China ...

Happy Buy Reached Cooperation With Hive-Box, Testing Water In Community E-Commerce

2020-09-17 22:00 17074

NANPING, China, Sept. 17, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that C'est La Vie Interactive Technology Co., Ltd ("CLV") , a subsidiary of Happy Buy, has signe...

Asia-Pacific's 5G Digital Factory Revenue Primed for a Post-COVID-19 Recovery Worth US$60 Billion in 2030

2020-09-17 20:30 3264

SINGAPORE, Sept. 17, 2020 /PRNewswire/ -- COVID-19 initially slowed mobile phone sales in theAsia Pacific and disrupted supply chains and demand for certain 5G-related end verticals. However, it also caused an increase in broadband traffic and 5G use cases such asSouth Korea using 5G to livestrea...

Turkish Student Received Full Scholarship to Pursue Dream at The University of Hong Kong

2020-09-17 20:00 945

ISTANBUL, Sept. 17, 2020 /PRNewswire/ -- The University of Hong Kong (HKU) established the HKU Scholarship for Future Leaders in the 2019/20 academic year to support talented students from developing countries to pursue their dreams at HKU. Applications were received from students inGhana, Madaga...

China's Weifang, Ecuador's Guaranda ink ties and join hands in COVID-19 fight

2020-09-17 19:13 892

WEIFANG, China, Sept. 17, 2020 /PRNewswire/ -- A video conference to share experiences of effective fight against the COVID-19 was held onSept. 11, when a signing ceremony of friendly and cooperative relations between Weifang City in China and Guaranda City in Ecuador also took place, according to...

Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2020

2020-09-17 19:00 15986

HONG KONG, Sept. 17, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 20...

1234567 ... 95